| |
| |
|
| Insider
Information: |
Theuer Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
453,445 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$108,787 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
453,445 |
|
|
| Total
Value |
$108,787 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
39
|
0
|
|
Stock
price went up :
|
18
|
0
|
| Stock
price went down : |
21
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 102.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tracon Pharmaceuticals, Inc. |
TCON |
|
2023-10-20 |
406,417 |
|
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2019-06-07 |
14,677 |
2019-06-07 |
0 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-10 |
32,351 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCON |
Tracon Pharmaceuticals, I... |
PRESIDENT AND CEO |
• • – |
2023-10-20 |
4 |
A |
$0.13 |
$467 |
D/D |
3,500 |
406,417 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-04-27 |
4 |
B |
$0.75 |
$35,250 |
D/D |
47,000 |
399,417 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-04-26 |
4 |
B |
$0.66 |
$2,639 |
D/D |
3,999 |
352,417 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
PRESIDENT AND CEO |
• • – |
2023-04-20 |
4 |
A |
$0.14 |
$482 |
D/D |
3,500 |
402,917 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-03-01 |
4 |
B |
$1.52 |
$7,296 |
D/D |
4,800 |
344,918 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-02-28 |
4 |
B |
$1.52 |
$304 |
D/D |
200 |
340,118 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-01-18 |
4 |
B |
$1.62 |
$11,016 |
D/D |
6,800 |
339,918 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-12-14 |
4 |
B |
$1.29 |
$29,755 |
D/D |
23,000 |
333,118 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-18 |
4 |
B |
$1.41 |
$19,599 |
D/D |
13,900 |
310,118 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-03 |
4 |
B |
$1.52 |
$13,984 |
D/D |
9,200 |
296,218 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-02 |
4 |
B |
$1.59 |
$9,540 |
D/D |
6,000 |
287,018 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-10-07 |
4 |
B |
$1.77 |
$8,850 |
D/D |
5,000 |
277,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-10-03 |
4 |
B |
$1.67 |
$8,350 |
D/D |
5,000 |
272,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-09-22 |
4 |
B |
$1.76 |
$8,800 |
D/D |
5,000 |
267,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-07-22 |
4 |
B |
$1.85 |
$8,325 |
D/D |
4,500 |
262,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-07-13 |
4 |
B |
$1.84 |
$5,520 |
D/D |
3,000 |
258,018 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-07-12 |
4 |
B |
$1.87 |
$5,610 |
D/D |
3,000 |
255,018 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-05-09 |
4 |
B |
$1.85 |
$18,500 |
D/D |
10,000 |
252,018 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-05-06 |
4 |
B |
$1.97 |
$4,925 |
D/D |
2,500 |
242,018 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-04-29 |
4 |
B |
$1.97 |
$9,855 |
D/D |
5,000 |
239,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-04-21 |
4 |
B |
$2.30 |
$10,350 |
D/D |
4,500 |
234,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-04-08 |
4 |
B |
$2.50 |
$5,000 |
D/D |
2,000 |
226,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-03-30 |
4 |
B |
$2.70 |
$10,800 |
D/D |
4,000 |
224,518 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-03-21 |
4 |
B |
$2.45 |
$2,940 |
D/D |
1,200 |
220,518 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2021-11-05 |
4 |
B |
$3.41 |
$13,655 |
D/D |
4,000 |
215,137 |
2.81 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
